Philip Hamptonwill retires as GlaxoSmithKline Plc‘s chairman

The drugmaker has begun the process of searching for Philip Hamptonwill’s successor.

On Monday, drugmaker GlaxoSmithKline plc stated, Philip Hamptonwill, its chairman will be stepping down from his role.

Hamptonwill has been GlaxoSmithKline’s chairman for more than three and a half years.

GSK stated, it has begun the process of searching for Hamptonwill’s successor.

Advertisements


Categories: Creativity, Entrepreneurship, HR & Organization, Strategy

Tags: , , , , , , , , ,

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: